Tuesday, 6 September 2016

Danaher to buy Cepheid for about $4 billion, including debt

(Reuters) - Danaher Corp said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics unit.


No comments:

Post a Comment